Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Ferguson

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
SSRI Antidepressant Medications: Adverse Effects and TolerabilityJames M. Ferguson
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Depression: Diagnosis and Management for the Primary Care PhysicianJames M. Ferguson
Gerontology|January 28, 2006
Pharmacokinetics of fluoxetine in elderly men and womenJames M Ferguson, Heather Hill
Bioinformatics (Oxford, England)|July 24, 2019
SquiggleKit: a toolkit for manipulating nanopore signal dataJames M Ferguson, Martin A Smith
Clinical Neuropharmacology|June 5, 2007
An open-label, flexible-dose study of memantine in major depressive disorderJames M Ferguson, Richard N Shingleton
Journal of Clinical Psychopharmacology|January 25, 2003
The antidepressant efficacy of reboxetine in patients with severe depressionStuart Montgomery, James M Ferguson, Gerri E Schwartz
CNS Spectrums|August 14, 2012
High-dose desvenlafaxine in outpatients with major depressive disorderJames M Ferguson, Karen A Tourian, Gregory R Rosas
International Clinical Psychopharmacology|December 20, 2002
Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patientsJames M Ferguson, Keith A Wesnes, Gerri E Schwartz
IEEE Transactions on Robotics : a Publication of the IEEE Robotics and Automation Society|October 28, 2024
Unified Shape and External Load State Estimation for Continuum RobotsJames M Ferguson, D Caleb Rucker, Robert J Webster
Bioinformatics (Oxford, England)|May 30, 2023
Accelerated nanopore basecalling with SLOW5 data formatHiruna Samarakoon, James M Ferguson, Hasindu Gamaarachchi, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
SSRI Antidepressant Medications: Adverse Effects and TolerabilityJames M. Ferguson
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Depression: Diagnosis and Management for the Primary Care PhysicianJames M. Ferguson
Gerontology|January 28, 2006
Pharmacokinetics of fluoxetine in elderly men and womenJames M Ferguson, Heather Hill
Bioinformatics (Oxford, England)|July 24, 2019
SquiggleKit: a toolkit for manipulating nanopore signal dataJames M Ferguson, Martin A Smith
Clinical Neuropharmacology|June 5, 2007
An open-label, flexible-dose study of memantine in major depressive disorderJames M Ferguson, Richard N Shingleton
Journal of Clinical Psychopharmacology|January 25, 2003
The antidepressant efficacy of reboxetine in patients with severe depressionStuart Montgomery, James M Ferguson, Gerri E Schwartz
CNS Spectrums|August 14, 2012
High-dose desvenlafaxine in outpatients with major depressive disorderJames M Ferguson, Karen A Tourian, Gregory R Rosas
International Clinical Psychopharmacology|December 20, 2002
Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patientsJames M Ferguson, Keith A Wesnes, Gerri E Schwartz
IEEE Transactions on Robotics : a Publication of the IEEE Robotics and Automation Society|October 28, 2024
Unified Shape and External Load State Estimation for Continuum RobotsJames M Ferguson, D Caleb Rucker, Robert J Webster
Bioinformatics (Oxford, England)|May 30, 2023
Accelerated nanopore basecalling with SLOW5 data formatHiruna Samarakoon, James M Ferguson, Hasindu Gamaarachchi, et al.
Pageof 5